Literature DB >> 17336502

Increased hemodynamic response in the hippocampus, thalamus and prefrontal cortex during abnormal sensory gating in schizophrenia.

Jason R Tregellas1, Deana B Davalos, Donald C Rojas, Merilyne C Waldo, Linzi Gibson, Korey Wylie, Yiping P Du, Robert Freedman.   

Abstract

OBJECTIVE: Deficits in sensory gating are a common feature of schizophrenia. Failure of inhibitory gating mechanisms, shown by poor suppression of evoked responses to repeated auditory stimuli, has been previously studied using EEG methods. These methods yield information about the temporal characteristics of sensory gating deficits, but do not identify brain regions involved in the process. Hence, the neuroanatomical substrates of poor sensory gating in schizophrenia remain largely unknown. This study used functional magnetic resonance imaging (fMRI) to investigate the functional neuroanatomy of sensory gating deficits in schizophrenia.
METHODS: Twelve patients with schizophrenia and 12 healthy comparison subjects were scanned at 3 Tesla while performing a sensory gating task developed for fMRI. P50 EEG evoked potential recordings from a paired-stimulus conditioning-test paradigm were obtained from the same subjects.
RESULTS: Compared to healthy comparison subjects, patients with schizophrenia exhibited greater activation in the hippocampus, thalamus, and dorsolateral prefrontal cortex (DLPFC) during the fMRI sensory gating task. No group difference was observed in the superior temporal gyrus. Schizophrenia subjects also showed decreased P50 suppression as measured with EEG. Hemodynamic response in the fMRI measure was positively correlated with test/conditioning ratios from the EEG sensory gating measure.
CONCLUSIONS: Poor sensory gating in schizophrenia is associated with dysfunction of an apparent network of brain regions, including the hippocampus, thalamus and DLPFC. Greater activation of these regions is consistent with evidence for diminished inhibitory function in schizophrenia.

Entities:  

Mesh:

Year:  2007        PMID: 17336502      PMCID: PMC2726714          DOI: 10.1016/j.schres.2006.12.033

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  38 in total

1.  Auditory brainstem responses with optimized chirp signals compensating basilar-membrane dispersion.

Authors:  T Dau; O Wegner; V Mellert; B Kollmeier
Journal:  J Acoust Soc Am       Date:  2000-03       Impact factor: 1.840

2.  Increased medial temporal lobe activation during the passive viewing of emotional and neutral facial expressions in schizophrenia.

Authors:  Daphne J Holt; Laura Kunkel; Anthony P Weiss; Donald C Goff; Christopher I Wright; Lisa M Shin; Scott L Rauch; Jessica Hootnick; Stephan Heckers
Journal:  Schizophr Res       Date:  2005-12-27       Impact factor: 4.939

3.  Sensory gating in the human hippocampal and rhinal regions.

Authors:  N N Boutros; P Trautner; T Rosburg; O Korzyukov; T Grunwald; C Schaller; C E Elger; M Kurthen
Journal:  Clin Neurophysiol       Date:  2005-08       Impact factor: 3.708

4.  Distribution of GABA(B) binding sites in the thalamus and basal ganglia of the rhesus monkey (Macaca mulatta).

Authors:  N G Bowery; K Parry; G Goodrich; I Ilinsky; K Kultas-Ilinsky
Journal:  Neuropharmacology       Date:  1999-11       Impact factor: 5.250

5.  Probing the human hippocampus using rCBF: contrasts in schizophrenia.

Authors:  D R Medoff; H H Holcomb; A C Lahti; C A Tamminga
Journal:  Hippocampus       Date:  2001       Impact factor: 3.899

6.  Beyond hypofrontality: a quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia.

Authors:  David C Glahn; J Daniel Ragland; Adir Abramoff; Jennifer Barrett; Angela R Laird; Carrie E Bearden; Dawn I Velligan
Journal:  Hum Brain Mapp       Date:  2005-05       Impact factor: 5.038

7.  Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia.

Authors:  Adrienne C Lahti; Martin A Weiler; Henry H Holcomb; Carol A Tamminga; William T Carpenter; Robert McMahon
Journal:  Neuropsychopharmacology       Date:  2006-01       Impact factor: 7.853

8.  Cross-modal generality of the gating deficit.

Authors:  J Christopher Edgar; Gregory A Miller; Sandra N Moses; Robert J Thoma; Ming-Xiong Huang; Faith M Hanlon; Michael P Weisend; Andrea Sherwood; Juan Bustillo; Larry E Adler; José M Cañive
Journal:  Psychophysiology       Date:  2005-05       Impact factor: 4.016

9.  Neuronal substrates of sensory gating within the human brain.

Authors:  Thomas Grunwald; Nashaat N Boutros; Nico Pezer; Joachim von Oertzen; Guillen Fernández; Carlo Schaller; Christian E Elger
Journal:  Biol Psychiatry       Date:  2003-03-15       Impact factor: 13.382

10.  Abnormalities of thalamic activation and cognition in schizophrenia.

Authors:  Jessica Andrews; Lei Wang; John G Csernansky; Mokhtar H Gado; Deanna M Barch
Journal:  Am J Psychiatry       Date:  2006-03       Impact factor: 18.112

View more
  69 in total

1.  Distinct neural generators of sensory gating in schizophrenia.

Authors:  Terrance J Williams; Keith H Nuechterlein; Kenneth L Subotnik; Cindy M Yee
Journal:  Psychophysiology       Date:  2010-08-23       Impact factor: 4.016

Review 2.  How human electrophysiology informs psychopharmacology: from bottom-up driven processing to top-down control.

Authors:  J Leon Kenemans; Seppo Kähkönen
Journal:  Neuropsychopharmacology       Date:  2010-10-06       Impact factor: 7.853

3.  Reduced Chrna7 expression in mice is associated with decreases in hippocampal markers of inhibitory function: implications for neuropsychiatric diseases.

Authors:  C E Adams; J C Yonchek; K M Schulz; S L Graw; J Stitzel; P U Teschke; K E Stevens
Journal:  Neuroscience       Date:  2012-01-25       Impact factor: 3.590

4.  P50 inhibitory sensory gating in schizophrenia: analysis of recent studies.

Authors:  Robert Freedman; Amanda M Olsen-Dufour; Ann Olincy
Journal:  Schizophr Res       Date:  2020-02-13       Impact factor: 4.939

5.  Intrinsic hippocampal activity as a biomarker for cognition and symptoms in schizophrenia.

Authors:  Jason R Tregellas; Jason Smucny; Josette G Harris; Ann Olincy; Keeran Maharajh; Eugene Kronberg; Lindsay C Eichman; Emma Lyons; Robert Freedman
Journal:  Am J Psychiatry       Date:  2014-05       Impact factor: 18.112

Review 6.  Neuroimaging biomarkers for early drug development in schizophrenia.

Authors:  Jason R Tregellas
Journal:  Biol Psychiatry       Date:  2013-10-04       Impact factor: 13.382

7.  Sensory gating disturbances in the spectrum: similarities and differences in schizotypal personality disorder and schizophrenia.

Authors:  Erin A Hazlett; Ethan G Rothstein; Rui Ferreira; Jeremy M Silverman; Larry J Siever; Ann Olincy
Journal:  Schizophr Res       Date:  2014-12-05       Impact factor: 4.939

8.  Increased hippocampal, thalamic, and prefrontal hemodynamic response to an urban noise stimulus in schizophrenia.

Authors:  Jason R Tregellas; Jamey Ellis; Shireen Shatti; Yiping P Du; Donald C Rojas
Journal:  Am J Psychiatry       Date:  2009-01-15       Impact factor: 18.112

9.  Superior temporal gyrus spectral abnormalities in schizophrenia.

Authors:  J Christopher Edgar; Faith M Hanlon; Ming-Xiong Huang; Michael P Weisend; Robert J Thoma; Bruce Carpenter; Karsten Hoechstetter; José M Cañive; Gregory A Miller
Journal:  Psychophysiology       Date:  2008-07-24       Impact factor: 4.016

10.  Profile of auditory information-processing deficits in schizophrenia.

Authors:  Bruce I Turetsky; Warren B Bilker; Steven J Siegel; Christian G Kohler; Raquel E Gur
Journal:  Psychiatry Res       Date:  2008-11-06       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.